GlassScriptPhysician profile
Stephen V Dreskin
NPI 1386648160
$1,912.14
in general payments reported to CMS, 2019-2025
16 companies · $328 in 2025
The $328 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $117 · 2021: $91.57 · 2022: $229 · 2023: $315 · 2024: $699 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,342.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $758.86 | 2019-2025 | Ztlido |
| Boston Scientific Corporation | $311.59 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Abbvie INC. | $269.64 | 2022-2025 | Ubrelvy, Vraylar, Qulipta |
| Medtronic, INC. | $200.10 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $90.94 | 2019-2023 | Relistor |
| Pfizer INC. | $78.93 | 2019-2025 | |
| Nalu Medical, INC. | $48.31 | 2024 | Nalu Neurostimulation System |
| Abbott Laboratories | $32.71 | 2020-2024 | Eterna |
| Arbor Pharmaceuticals, INC. | $27.63 | 2019 | |
| Idorsia Pharmaceuticals US INC | $20.67 | 2024 | Quviviq |
| Horizon Therapeutics Plc | $16.20 | 2022 | |
| Alexion Pharmaceuticals, INC. | $14.15 | 2019 | |
| Medtronic USA, INC. | $13.87 | 2020 | |
| Assertio Therapeutics, INC. | $13.81 | 2019 | |
| Daiichi Sankyo INC. | $12.64 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Epimed International, INC | $2.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Dreskin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.